Arteriosclerosis  >>  inclacumab (PF-07940370)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
inclacumab (PF-07940370) / Roche, Pfizer, Genmab
NCT00760565: A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).

Completed
1
72
US, Canada, RoW
RO4905417, placebo
Hoffmann-La Roche
Peripheral Arterial Disease (PAD)
06/11
06/11

Download Options